跳至主要内容
临床试验/NCT01135095
NCT01135095已完成不适用

Validation of a Low-Dose One-Day TC99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera for Detection of Coronary Artery Disease

Spectrum Dynamics4 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2010年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
101
试验地点
4
主要终点
Summed Rest Score (SRS) Using American Heart Association 17 Segment Polar Map Model

研究概览

简要总结

A prospective single clinical trial to validate the use of a low-dose (~5mSv) Tc-99m protocol with a high-efficiency cardiac dedicated camera (Dynamic Single Photon Emission Computed Tomography; D-SPECT) to detect myocardial perfusion abnormalities during myocardial perfusion imaging.

详细描述

as above

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is referred to myocardial perfusion D-SPECT for clinical indications.
  • Written informed consent is obtained by a study investigator.

排除标准

  • Patient is diagnosed as having uncontrolled congestive cardiac failure or cardiogenic shock.
  • Patient is diagnosed as having uncontrolled hypertension with resting blood pressure > 220 mm Hg systolic or 110 mm Hg diastolic.
  • Patient pregnancy (known or suspected).
  • Lack of written informed consent
  • Prisoner status
  • Minors under the age of 18 as coronary artery disease is generally an adult disease

结局指标

主要结局

Summed Rest Score (SRS) Using American Heart Association 17 Segment Polar Map Model

时间窗: 1 day

SRS is used to quantify presence/severity of SPECT rest myocardial perfusion defects, as assessed by visual analysis using American Heart Association (AHA) 17 segment polar map model; each segment correlates to a myocardial location. Perfusion abnormalities can be determined in relation to myocardial segment/s affected by ischemia and the perfusion defect severity scored using 0 - 4 scale for each segment (0, normal uptake; 1, mildly reduced uptake; 2, moderately reduced uptake; 3, severely reduced uptake; and 4, no uptake). SRS is calculated by summing individual scores from each of 17 segments to give an overall score between 0 and 68; a score of 0 indicates normal outcome and scores \> 0 indicate increasingly worse outcomes as the score increases. For each patient, SRS will be compared between standard-low-dose (SLD) imaging from a conventional A-SPECT camera and ultra-low-dose (ULD) imaging from a high-efficiency D-SPECT camera, both acquired on the same day.

次要结局

未报告次要终点

研究者

发起方
Spectrum Dynamics
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验